SEC Form 4 · accession 0000899243-19-006263
CareDx, Inc. · CDNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Brian Bell
Officer — Chief Financial Officer
Period of report
Mar 1, 2019
Accepted (ET)
Mar 5, 2019 · 6:56 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001217234
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 1, 2019 | A | 25,000 | $0.00 | A | 102,060 | D | |
| Common StockF2 | Mar 1, 2019 | F | 11,770 | $31.64 | D | 90,290 | D | |
| Common StockF4 | Mar 1, 2019 | S | 13,000 | $31.3648 | D | 77,290 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reported securities were represented by restricted performance stock units that were granted on October 20, 2017, 100% of which vested on March 1, 2019 upon the achievement of the requisite performance criteria.
- F2These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units.
- F3The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.15 to $31.495, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.